Results 91 to 100 of about 12,045 (211)
A New Interpretation of the Standard PSA-Test
Ernesto P Esteban,1 Lusmeralis Almodovar-Abreu2 1Physics Department, University of Puerto Rico-Humacao, Humacao 00791, Puerto Rico; 2Chemistry Department, University of Puerto Rico-Humacao, Humacao 00791, Puerto RicoCorrespondence: Ernesto P ...
Esteban EP, Almodovar-Abreu L
doaj
ABSTRACT Children in out‐of‐home care (OOHC) frequently present with complex behavioural needs. In New South Wales (NSW), behaviour support plans (BSPs) are mandated when restrictive practices, including psychotropic medication, are used. Little research has examined whether the statutory workforce is adequately prepared to meet behaviour support ...
Manisha Abayakoon Stanborough +4 more
wiley +1 more source
Objective To assess guselkumab + golimumab combination therapy versus guselkumab monotherapy in participants with active psoriatic arthritis (PsA) and inadequate response to tumor necrosis factor inhibitors (TNFi‐IR). Methods Adults with active TNFi‐IR PsA (three or more tender/swollen joints) were randomized (2:1) to subcutaneous guselkumab (100 mg) +
Jose U. Scher +12 more
wiley +1 more source
Objective To identify autoantibodies in presymptomatic individuals that associate with the onset of rheumatoid arthritis (RA) and to distinguish early RA from osteoarthritis (OA), particularly in individuals lacking classic RA serologic markers. Methods We analyzed serum and plasma from three cohorts: presymptomatic individuals who later developed RA ...
Outi Sareila +12 more
wiley +1 more source
Objective Axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) are overlapping yet distinct conditions within the SpA spectrum. As divergent immunophenotypes may influence disease course and therapeutic response, we compared immune cell subsets, cytokine profiles, and inflammatory mediators.
Natalie Frede +11 more
wiley +1 more source
Objective The purpose of this study was to assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients aged 2 to 17 years with ...
Hermine I. Brunner +52 more
wiley +1 more source
Monu Deswal,1 Durgavati Yadav,1 Vinay Kumar,2 Meenakshi Meenu,3 Pranay Tanwar,4 Shivani Srivastava,5 Prabhjot Singh,1 Kumar Sandeep6 1Department of Urology, All India Institute of Medical Sciences, New Delhi, India; 2Heart and Vascular Institute ...
Deswal M +7 more
doaj
Prostate Cancer Screening Guidelines: To PSA or Not to PSA?
Abstract Prostate cancer (PCa) screening with PSA (prostate-specific antigen) remains controversial. PSA is specific to the organ but not to cancer, and different benign conditions can influence the value, which may lead to false-positive results. Treatment with 5α-reductase inhibitors decreases the PSA value, and therefore, it is vital to have a ...
Anja Badenhorst +3 more
openaire +2 more sources

